Latest Lazard Stories

PHILADELPHIA, Nov. 12, 2010 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, is scheduled to present at Lazard Capital Markets' 7th Annual Healthcare Conference at 10:55 AM EST on November 16, 2010 in New York City, New York. Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com. The webcast may also be accessed at http://www.wsw.com/webcast/lz8/eres/. The...

FRAMINGHAM, Mass. and SYDNEY, Nov. 11, 2010 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to make an investor presentation at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17, at 1:15 pm EST. The conference will be held November...

PALO ALTO, Calif., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, the company's chairman and chief executive officer, will present at the Lazard Capital Markets Healthcare Conference in New York on Wednesday, November 17, 2010 at 9:00 a.m. Eastern Time. A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the...

CINCINNATI, Nov. 11, 2010 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Lazard Capital Markets 7th Annual Healthcare Conference on Nov. 16, 2010 at the St. Regis New York in New York City. Kendle's formal presentation will be given at 2:10 p.m. Eastern Time by Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer and Keith Cheesman, Senior Vice...

ROCKVILLE, Md., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax will be presenting at the Lazard 7th Annual Healthcare Conference. The presentation will take place on Tuesday, November 16, 2010 at 1:10pm local time at the St. Regis Hotel, New York, NY. An audio link to the live presentation can be accessed via the Company website at...

SAN MATEO, Calif., Nov. 10, 2010 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the Lazard Capital Markets 7th Annual Healthcare Conference, to be held November 16-17, 2010 at the St. Regis Hotel in New York, NY. Event: Lazard Capital Markets 7th Annual Healthcare...

LYNBROOK, N.Y., Nov. 10, 2010 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17, 2010, at 2:45 pm ET at The St. Regis in New York, New York. A live webcast of the presentation can be accessed under "Calendar of Events"...

WALTHAM, Mass., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17th, 2010 at 2:45 p.m. EST at the St. Regis Hotel, 2 East 55th Street, New York, NY. A live audio webcast of the presentation will be available via Repligen's website at www.repligen.com and will be...

WALTHAM, Mass., Nov. 9, 2010 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Lazard Capital Markets 7th Annual Healthcare Conference being held November 16 - 17, 2010 at the St. Regis, New York. Jon Russell, Vice President, Finance, will attend. Mr. Russell's presentation is scheduled for Wednesday, November 17, 2010...

NES-ZIONA, Israel, Nov. 9, 2010 /PRNewswire/ -- PROLOR Biotech, Inc., (NYSE Amex: PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will give a corporate presentation at the Lazard Capital Markets 7th Annual Healthcare Conference, to be held at the St. Regis Hotel in New York City. The presentation is scheduled for November 17, 2010 at 9:30 AM ET. A live webcast of the company's presentation will be available...